MANE
Veradermics, Incorporated
There isn't enough reported data to score MANE yet.
MANE Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
MANE's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
MANE PE Valuation
MANE has no meaningful PE right now: it lost money over the past year.
MANE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| -- | |
| -- | |
| Limited | |
| High |
Analysts expect MANE's losses to shrink, with revenue holding steady.
MANE Earnings Per Share
MANE Quarterly Revenue
MANE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.3M | -$4.3M |
| Q2 2026 | -$14.5M | +$1.1M |
| Q1 2026 | -$21.2M | -$7.8M |
| Q4 2025 | -$23.6M | -$20M |
MANE has burned cash in almost every quarter: −$83M over the past year, against −$52M the year before.
MANE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.2% | +1.7M shares |
| 1 year | +20% | +7M shares |
MANE has 42M diluted shares, up 20% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
MANE Net Leverage
MANE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MANE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.1 | Neutral |
| Stochastic | 79.4 | Neutral |
MANE's weekly RSI is 64 (neutral) and its Stochastic is 79 (neutral).
MANE PE vs Healthcare Sector
MANE has no meaningful PE right now: it lost money over the past year.
MANE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $128.2 | 5.5% above |
| 20 week MA | $116.6 | 16% above |
MANE is in an uptrend: it's above all two of its weekly moving averages, and 16% above its 20-week average.
MANE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $38.5 | $135.3 | +252% |
It's up 252% so far in 2026.